Welcome!

News Feed Item

The 15th Annual BioEquity Europe Conference Features More Than 100 Innovator Companies With Differentiated Products, Upcoming Milestones and Partner-Ready Assets

Two Days of Plenary Sessions Examine How European Companies Are Stepping Up to Play in Biotech's Premier League

REDWOOD CITY, CA -- (Marketwired) -- 05/20/14 -- BioCentury, EBD Group and the Biotechnology Industry Organization (BIO) will convene the 15th Annual BioEquity Europe conference in Amsterdam on Wednesday, May 21, and Thursday, May 22, at the Hilton Amsterdam Hotel. More than 500 life science investment professionals and pharmaceutical business development and licensing executives have registered. Walk-up registration is available at the Hilton Amsterdam Hotel starting at 7:45 a.m. on May 21.

BioEquity Europe is the seminal industry event for financial dealmakers looking for investor-validated life science companies positioning themselves to attract capital, and for pharmaceutical licensing professionals to assess top prospects.

In 2014, the conference will showcase presentations by 68 mature and 42 newly formed innovator biopharma companies. The Presenting Companies have been hand-picked by BioCentury on the basis of investor validation, upcoming milestones and unpartnered assets. The slate of Next Wave Companies features fresh opportunities for venture capital investment and early stage partnering opportunities in the biotech space.

More than half a dozen plenaries and Q&A sessions over the two days will feature 45 key opinion leaders. These sessions will be highlighted by a fireside chat with Dr. Jordi Llinares-Garcia -- EMA's Head of Product Development Scientific Support Department and former Head of Orphan Drugs. During this session, BioCentury's Chairman & Editor-in-Chief Dr. Karen Bernstein will interview Dr. Llinares-Garcia about how the agency acts as an "enabler" for smaller players, including academia, in the pharmaceutical innovation ecosystem.

Back by popular demand is the BioCentury/Ernst & Young Face-Off. At the Face-Off, BioCentury will unveil its 12th annual "European Iceberg" report, which projects funding demands by Europe's clinical stage biotechnology companies, and Ernst & Young will provide analysis from its 28th annual "Beyond Borders Global Biotechnology Report." The Face-Off will be chaired by Susan Schaeffer, Editor of BioCentury, and Jürg Zürcher, Partner, EMEIA Biotechnology Leader, Ernst & Young.

Other plenaries will focus on how European biotechs can better compete with U.S. companies for capital, and how European science stands up against a global playing field.

"The full slate of presenting companies, distinguished faculty and strong pre-registration numbers indicate a renewed interest in European biotechs by the investment and licensing communities," said BioCentury Publisher Eric Pierce. "The compelling stories from the Class of 2014, coupled with high-impact discussions with our international faculty, make BioEquity Europe a must-attend event for investors and business development and licensing professionals."

See the complete program, including presenting companies, plenary schedules and a list of the 2014 faculty at http://www.biocentury.com/conferences/bioequityeurope/dates/schedule.

The 2014 BioEquity Europe Presenting Companies
Presenting companies were screened using BioCentury's industry analysis and proprietary databases, including BioCentury's BCIQ online business intelligence platform. The result is an independently selected mix of companies with proven fundraising ability, prospects for key partnerships and proximity to potentially transformational milestones.

View the complete list of presenting companies and Next Wave Presenting Companies at http://www.biocentury.com/conferences/bioequityeurope/companies/presentingcompanies.

The BioEquity Europe Sponsors & Regional Host Committee
This unique turf-neutral setting is made possible by the support of the region's life science organizations and BioEquity Europe's Sponsors. The Regional Host Committee is comprised of Amsterdam BioMed Cluster/Amsterdam Economic Board, Axon, Deloitte and Van Campen Liem.

The prestigious group of 2014 sponsors is anchored by Gold Sponsors Ernst & Young, MS Ventures and Sofinnova Partners and Silver Sponsors Abingworth, AstraZeneca, Boehringer Ingelheim Venture Fund, Edwards Wildman, Geller Biopharm, Gilde Healthcare, Index Ventures, Inserm Transfert Initiative, Johnson & Johnson Innovation, LSP-Life Sciences Partners, Oxford Finance, Piper Jaffray and Roche Venture Fund.

About BioCentury
Since 1993, BioCentury Publications, Inc. has provided essential biopharma industry intelligence to a global audience of biotech and pharmaceutical executives, investors, regulators and public policy makers, and the scientific community. This audience has benefited from BioCentury's deep knowledge, data-driven analysis, independent perspective and trustworthy content available through the company's publications, television, data products and collaborative industry conferences in the U.S., Europe and Asia.

BioEquity Europe is one of three annual investor conferences organized by BioCentury. The next conference, NewsMakers in the Biotech Industry, will take place on Sept. 26, 2014, followed by Future Leaders in the Biotech Industry, on March 20, 2015. Both events will take place at the Millennium Broadway Hotel & Conference Center in New York City.

For more information, visit www.biocentury.com and www.biocenturytv.com.

About EBD Group
EBD Group is the leading partnering firm for the global life science industry. Since 1993, biotech, pharma and medical device companies have leveraged EBD Group's partnering conferences, technology and services to identify business opportunities and develop strategic relationships essential to their success.

EBD Group's conferences are run with the support of leading corporations and international trade associations and include:

  • BIO-Europe® and BIO-Europe Spring®, supported by the Biotechnology Industry Organization (BIO)
  • BioPharm America™
  • Biotech Showcase™, co-produced with Demy-Colton Life Science Advisors
  • BioEquity Europe, co-organized with BioCentury Publications and BIO
  • ChinaBio® Partnering Forum, co-produced with ChinaBio® LLC
  • EuroMedtech™
  • Partnering for Global Impact®

EBD Group's sophisticated web-based partnering service, partneringONE®, is used as the partnering engine at numerous third-party events around the world, and partnering360® is the open online community of life science dealmakers that enhances partnering experiences throughout the year.

EBD Group is an Informa company. Informa is the largest publicly owned organizer of exhibitions, conferences and training in the world.

EBD Group has offices in the USA and Europe.

About the Biotechnology Industry Organization
BIO represents more than 1,200 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the U.S. and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world's largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world.

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.

Latest Stories
All clouds are not equal. To succeed in a DevOps context, organizations should plan to develop/deploy apps across a choice of on-premise and public clouds simultaneously depending on the business needs. This is where the concept of the Lean Cloud comes in - resting on the idea that you often need to relocate your app modules over their life cycles for both innovation and operational efficiency in the cloud. In his session at @DevOpsSummit at19th Cloud Expo, Valentin (Val) Bercovici, CTO of Soli...
"We're a cybersecurity firm that specializes in engineering security solutions both at the software and hardware level. Security cannot be an after-the-fact afterthought, which is what it's become," stated Richard Blech, Chief Executive Officer at Secure Channels, in this SYS-CON.tv interview at @ThingsExpo, held November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA.
"IoT is going to be a huge industry with a lot of value for end users, for industries, for consumers, for manufacturers. How can we use cloud to effectively manage IoT applications," stated Ian Khan, Innovation & Marketing Manager at Solgeniakhela, in this SYS-CON.tv interview at @ThingsExpo, held November 3-5, 2015, at the Santa Clara Convention Center in Santa Clara, CA.
Information technology is an industry that has always experienced change, and the dramatic change sweeping across the industry today could not be truthfully described as the first time we've seen such widespread change impacting customer investments. However, the rate of the change, and the potential outcomes from today's digital transformation has the distinct potential to separate the industry into two camps: Organizations that see the change coming, embrace it, and successful leverage it; and...
Join Impiger for their featured webinar: ‘Cloud Computing: A Roadmap to Modern Software Delivery’ on November 10, 2016, at 12:00 pm CST. Very few companies have not experienced some impact to their IT delivery due to the evolution of cloud computing. This webinar is not about deciding whether you should entertain moving some or all of your IT to the cloud, but rather, a detailed look under the hood to help IT professionals understand how cloud adoption has evolved and what trends will impact th...
Data is the fuel that drives the machine learning algorithmic engines and ultimately provides the business value. In his session at Cloud Expo, Ed Featherston, a director and senior enterprise architect at Collaborative Consulting, discussed the key considerations around quality, volume, timeliness, and pedigree that must be dealt with in order to properly fuel that engine.
We are always online. We access our data, our finances, work, and various services on the Internet. But we live in a congested world of information in which the roads were built two decades ago. The quest for better, faster Internet routing has been around for a decade, but nobody solved this problem. We’ve seen band-aid approaches like CDNs that attack a niche's slice of static content part of the Internet, but that’s it. It does not address the dynamic services-based Internet of today. It does...
Internet of @ThingsExpo, taking place June 6-8, 2017 at the Javits Center in New York City, New York, is co-located with the 20th International Cloud Expo and will feature technical sessions from a rock star conference faculty and the leading industry players in the world. @ThingsExpo New York Call for Papers is now open.
What happens when the different parts of a vehicle become smarter than the vehicle itself? As we move toward the era of smart everything, hundreds of entities in a vehicle that communicate with each other, the vehicle and external systems create a need for identity orchestration so that all entities work as a conglomerate. Much like an orchestra without a conductor, without the ability to secure, control, and connect the link between a vehicle’s head unit, devices, and systems and to manage the ...
20th Cloud Expo, taking place June 6-8, 2017, at the Javits Center in New York City, NY, will feature technical sessions from a rock star conference faculty and the leading industry players in the world. Cloud computing is now being embraced by a majority of enterprises of all sizes. Yesterday's debate about public vs. private has transformed into the reality of hybrid cloud: a recent survey shows that 74% of enterprises have a hybrid cloud strategy.
Everyone knows that truly innovative companies learn as they go along, pushing boundaries in response to market changes and demands. What's more of a mystery is how to balance innovation on a fresh platform built from scratch with the legacy tech stack, product suite and customers that continue to serve as the business' foundation. In his General Session at 19th Cloud Expo, Michael Chambliss, Head of Engineering at ReadyTalk, discussed why and how ReadyTalk diverted from healthy revenue and mor...
"Qosmos has launched L7Viewer, a network traffic analysis tool, so it analyzes all the traffic between the virtual machine and the data center and the virtual machine and the external world," stated Sebastien Synold, Product Line Manager at Qosmos, in this SYS-CON.tv interview at 19th Cloud Expo, held November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA.
"We are a modern development application platform and we have a suite of products that allow you to application release automation, we do version control, and we do application life cycle management," explained Flint Brenton, CEO of CollabNet, in this SYS-CON.tv interview at DevOps at 19th Cloud Expo, held November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA.
The 20th International Cloud Expo has announced that its Call for Papers is open. Cloud Expo, to be held June 6-8, 2017, at the Javits Center in New York City, brings together Cloud Computing, Big Data, Internet of Things, DevOps, Containers, Microservices and WebRTC to one location. With cloud computing driving a higher percentage of enterprise IT budgets every year, it becomes increasingly important to plant your flag in this fast-expanding business opportunity. Submit your speaking proposal ...
You have great SaaS business app ideas. You want to turn your idea quickly into a functional and engaging proof of concept. You need to be able to modify it to meet customers' needs, and you need to deliver a complete and secure SaaS application. How could you achieve all the above and yet avoid unforeseen IT requirements that add unnecessary cost and complexity? You also want your app to be responsive in any device at any time. In his session at 19th Cloud Expo, Mark Allen, General Manager of...